David Colleran - Net Worth and Insider Trading

David Colleran Net Worth

The estimated net worth of David Colleran is at least $7 Million dollars as of 2024-11-05. David Colleran is the SVP, Secretary and GC of Insulet Corp and owns about 30,433 shares of Insulet Corp (PODD) stock worth over $7 Million. David Colleran is also the EVP, General Counsel, Corp Sec of Anika Therapeutics Inc and owns about 9,867 shares of Anika Therapeutics Inc (ANIK) stock worth over $160,388. Details can be seen in David Colleran's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Colleran has not made any transactions after 2022-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David Colleran

To

David Colleran Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Colleran owns 2 companies in total, including Anika Therapeutics Inc (ANIK) , and Insulet Corp (PODD) .

Click here to see the complete history of David Colleran’s form 4 insider trades.

Insider Ownership Summary of David Colleran

Ticker Comapny Transaction Date Type of Owner
ANIK Anika Therapeutics Inc 2022-05-11 EVP & General Counsel & Corp Sec
PODD Insulet Corp 2019-04-02 Secretary and General Counsel

David Colleran Latest Holdings Summary

David Colleran currently owns a total of 2 stocks. Among these stocks, David Colleran owns 30,433 shares of Insulet Corp (PODD) as of April 2, 2019, with a value of $7 Million and a weighting of 97.85%. David Colleran also owns 9,867 shares of Anika Therapeutics Inc (ANIK) as of May 11, 2022, with a value of $160,388 and a weighting of 2.15%.

Latest Holdings of David Colleran

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PODD Insulet Corp 2019-04-02 30,433 240.06 7,305,746
ANIK Anika Therapeutics Inc 2022-05-11 9,867 16.26 160,388

Holding Weightings of David Colleran


David Colleran Form 4 Trading Tracker

According to the SEC Form 4 filings, David Colleran has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 7,395 shares on April 2, 2019, which brought David Colleran around $701,712.

According to the SEC Form 4 filings, David Colleran has made a total of 2 transactions in Anika Therapeutics Inc (ANIK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Anika Therapeutics Inc is the acquisition of 1,500 shares on May 11, 2022, which cost David Colleran around $32,055.

Insider Trading History of David Colleran

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Colleran Trading Performance

GuruFocus tracks the stock performance after each of David Colleran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Colleran is -8.49%. GuruFocus also compares David Colleran's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Colleran within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Colleran's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Colleran

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.87 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.06 LIMIT LIMIT LIMIT LIMIT LIMIT

David Colleran Ownership Network

Ownership Network List of David Colleran

No Data

Ownership Network Relation of David Colleran

Insider Network Chart

David Colleran Owned Company Details

What does Anika Therapeutics Inc do?

Who are the key executives at Anika Therapeutics Inc?

David Colleran is the EVP & General Counsel & Corp Sec of Anika Therapeutics Inc. Other key executives at Anika Therapeutics Inc include SVP & Chief Operations Officer Anne Nunes , EVP & CFO & Treasurer Michael L Levitz , and EVP Business Development James Loerop .

Anika Therapeutics Inc (ANIK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anika Therapeutics Inc (ANIK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anika Therapeutics Inc (ANIK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anika Therapeutics Inc (ANIK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Anika Therapeutics Inc Insider Transactions

No Available Data

David Colleran Mailing Address

Above is the net worth, insider trading, and ownership report for David Colleran. You might contact David Colleran via mailing address: 600 Technology Park Drive, Suite 200, Billerica Ma 01821.